# Application of PLCL as a biodegradable polymer in biomedical engineering

**Authors:** Yonggang Zhao, Honglei Liu

PMC · DOI: 10.1007/s10856-026-07016-3 · Journal of Materials Science. Materials in Medicine · 2026-02-27

## TL;DR

This review summarizes the properties, preparation methods, and biomedical applications of PLCL, a biodegradable polymer with promising potential in various medical fields.

## Contribution

The paper provides a comprehensive and systematic review of PLCL's properties, processing methods, and biomedical applications.

## Key findings

- PLCL exhibits exceptional biocompatibility and is suitable for diverse biomedical applications.
- Modification strategies can enhance PLCL's performance for specific medical uses.
- PLCL is applied in wound healing, cardiovascular stents, nerve repair, and tissue engineering.

## Abstract

Poly (L-lactide-co-ε-caprolactone) (PLCL) is a novel polymer that has attracted considerable attention in the biomedical field due to its exceptional biocompatibility. However, a comprehensive and systematic summary of its diverse applications remains lacking. To address this gap, the present review outlines the physicochemical properties of PLCL and the factors that influence them. Additionally, it consolidates the most commonly employed processing and preparation methods for PLCL in biomedical applications. The review further provides a systematic overview of current applications of PLCL in various biomedical fields, including wound healing, cardiovascular stents, nerve repair, osteochondral tissue engineering, drug delivery, and screening. It also examines modification strategies aimed at enhancing PLCL performance. Ultimately, this review seeks to provide valuable insights for future research and development of PLCL in biomedical contexts.

## Full-text entities

- **Genes:** Igf1 (insulin-like growth factor 1) [NCBI Gene 24482] {aka IGF}, Akt1 (AKT serine/threonine kinase 1) [NCBI Gene 24185] {aka Akt}, Pik3cb (phosphatidylinositol-4,5-bisphosphate 3-kinase, catalytic subunit beta) [NCBI Gene 85243], FGF2 (fibroblast growth factor 2) [NCBI Gene 2247] {aka BFGF, FGF-2, FGFB, HBGF-2}, PLCL1 (phospholipase C like 1 (inactive)) [NCBI Gene 5334] {aka PLCE, PLCL, PLDL1, PPP1R127, PRIP}, Tgfb1 (transforming growth factor, beta 1) [NCBI Gene 59086] {aka Tgfb}, Nfe2l2 (NFE2 like bZIP transcription factor 2) [NCBI Gene 83619], Ngf (nerve growth factor) [NCBI Gene 310738] {aka Ngfb, beta-NGF}, VEGFA (vascular endothelial growth factor A) [NCBI Gene 7422] {aka L-VEGF, MVCD1, VEGF, VPF}, Hgf (hepatocyte growth factor) [NCBI Gene 24446] {aka HPTA}
- **Diseases:** trauma (MESH:D014947), inflammation (MESH:D007249), platelet aggregation (MESH:D001791), thrombosis (MESH:D013927), hyperglycemic (MESH:D006944), adhesions (MESH:D000267), death (MESH:D003643), colorectal cancer (MESH:D015179), developmental abnormalities (MESH:D006130), skin injury (MESH:D000069836), infected (MESH:D007239), urethral defect (MESH:D014526), Cardiovascular disease (MESH:D002318), diabetic (MESH:D003920), heart valve disease (MESH:D006349), myocardium defect (MESH:D017682), vascular-related diseases (MESH:D014652), cancer (MESH:D009369), calcification (MESH:D002114), Bone defects (MESH:D001847), cytotoxicity (MESH:D064420), bacterial infection (MESH:D001424), abdominal adhesions (MESH:D000007), SBS (MESH:D014717), tracheal defects (MESH:D014133), myocardial defect (MESH:D009202), Injury to the PNS (MESH:D010523), allergic reactions (MESH:D004342), osteoarthritis (MESH:D010003), bladder injury (MESH:D001745), intimal hyperplasia (MESH:D006965), skin defects (MESH:D012868)
- **Chemicals:** COG133 (-), dioxane (MESH:C025223), epigallocatechin gallate (MESH:C045651), chondroitin sulfate (MESH:D002809), silicate (MESH:D017640), dextran (MESH:D003911), phenol red (MESH:D010637), NO (MESH:D009614), silica (MESH:D012822), DOX (MESH:D004317), glycosaminoglycans (MESH:D006025), chitosan (MESH:D048271), Pluronic F127 (MESH:D020442), oxygen (MESH:D010100), silicone rubber (MESH:D012826), PTFE (MESH:D011138), L-lactate (MESH:D019344), dichloromethane (MESH:D008752), caprolactone (MESH:C121056), ester (MESH:D004952), PCL (MESH:C016240), hydroxyapatite (MESH:D017886), tert-butanol (MESH:D020002), polymer (MESH:D011108), SB (MESH:D000965), ZnO (MESH:D015034), water (MESH:D014867), citric acid (MESH:D019343), CO2 (MESH:D002245), lactide (MESH:C091880), beta-TCP (MESH:C485817), chloroform (MESH:D002725), DEX (MESH:D003915), PLA (MESH:C033616), MgO (MESH:D008277), PLGA (MESH:D000077182), silver (MESH:D012834), PVDF (MESH:C024865), MXene (MESH:C000723374), heparin (MESH:D006493), PGA (MESH:D011454), BG (MESH:C064976), SP (MESH:C000604007), HA (MESH:D006820)
- **Species:** Rattus norvegicus (brown rat, species) [taxon 10116], Homo sapiens (human, species) [taxon 9606], Oryctolagus cuniculus (domestic rabbit, species) [taxon 9986]
- **Cell lines:** PC12 — Rattus norvegicus (Rat), Rat adrenal gland pheochromocytoma, Cancer cell line (CVCL_0481), MC3T3 — Mus musculus (Mouse), Spontaneously immortalized cell line (CVCL_0D74), HT29 — Homo sapiens (Human), Colon adenocarcinoma, Cancer cell line (CVCL_0320), FDM — Homo sapiens (Human), Human papillomavirus-related endocervical adenocarcinoma, Cancer cell line (CVCL_B2IE)

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC12960328/full.md

## Figures

14 figures with captions in the complete paper: https://tomesphere.com/paper/PMC12960328/full.md

## References

11 references — full list in the complete paper: https://tomesphere.com/paper/PMC12960328/full.md

---
Source: https://tomesphere.com/paper/PMC12960328